Arcellx, Inc.
$115.07
The Read: Arcellx’s stock surged about 11% on Q4 2025 earnings due to Gilead’s $115-per-share acquisition deal, then rallied nearly 20% as the M&A offer replaced a feared capital raise, and subsequently stayed pinned near $115 amid tender offer progress and Anito-cel BLA acceptance.
ACLX
Hover to view data
No Data